Cornwall, United Kingdom

Diana Gillian Douglas

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Diana Gillian Douglas. Retrieved from https://idiyas.com/inventor/diana-gillian-douglas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 88(Granted Patents)


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Diana Gillian Douglas: Innovator in Pharmaceutical Chemistry

Introduction: Diana Gillian Douglas is a notable inventor based in Cornwall, GB, recognized for her significant contributions to the field of pharmaceutical chemistry. With a unique focus on developing innovative compounds, she has made strides in the treatment of diseases through her research and inventions.

Latest Patents: Diana holds one patent for her work on isoquinolinone derivatives. This patent details derivatives of isoquinolinone and dihydrolisoquinolinone, including related compounds. These innovations are significant for their application in pharmaceuticals, particularly in the treatment of diseases by inhibiting the enzyme poly(ADP-ribose) polymerase, commonly referred to as “PARP.”

Career Highlights: Throughout her career, Diana has focused on the intersection of chemistry and medicine, working diligently to enhance the efficacy of pharmaceutical compounds. Her inventive contributions stand out, particularly in an era where innovative solutions in drug development are paramount for patient care.

Collaborations: Diana has collaborated with esteemed professionals such as Niall Morrison Barr Martin and Graeme Cameron Murray Smith. These partnerships have enriched her research and development endeavors, leading to advancements in her field.

Conclusion: Diana Gillian Douglas exemplifies dedication and innovation in pharmaceutical chemistry. Her patent on isoquinolinone derivatives showcases her commitment to improving medical treatments through scientific discovery. As she continues her work, she remains a valuable contributor to the field, and her collaborations promise further advancements in pharmaceutical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…